Literature DB >> 15666333

Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues.

Elisabeth M Dykens1, James S Sutcliffe, Pat Levitt.   

Abstract

New insights into biological factors that underlie autism may be gained by comparing autism to other neurodevelopmental disorders that have autistic features and relatively well-delineated genetic etiologies or neurobiological findings. This review moves beyond global diagnoses of autism and instead uses an endophenotypic approach to compare specific clusters of autistic symptomatology to features of chromosome 15q11-q13 disorders. Paternally or maternally derived deficiencies of 15q11-q13 result in Prader-Willi or Angelman syndromes, and we first use a global approach to review potential autism susceptibility genes in the 15q11-q13 region. We then use a more trait-based approach to suggest possible ties between specific phenotypic characteristics of autism and Prader-Willi syndrome, namely savant-like skills. We conclude with insights from pathophysiological studies that implicate altered development of specific neuron types and circuits in the cerebral cortex as part of the pathophysiological processes associated with autism and mental retardation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15666333     DOI: 10.1002/mrdd.20042

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  30 in total

Review 1.  Brain-specific small nucleolar RNAs.

Authors:  Boris Rogelj
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Searching for autism symptomatology in children with epilepsy--a new approach to an established comorbidity.

Authors:  Beth A Malow
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

Review 3.  The genetics of autism spectrum disorders.

Authors:  Dorothy E Grice; Joseph D Buxbaum
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

Review 5.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

6.  Identification of chromosome 7 inversion breakpoints in an autistic family narrows candidate region for autism susceptibility.

Authors:  Holly N Cukier; David A Skaar; Melissa Y Rayner-Evans; Ioanna Konidari; Patrice L Whitehead; James M Jaworski; Michael L Cuccaro; Margaret A Pericak-Vance; John R Gilbert
Journal:  Autism Res       Date:  2009-10       Impact factor: 5.216

7.  Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.

Authors:  A Oguro-Ando; C Rosensweig; E Herman; Y Nishimura; D Werling; B R Bill; J M Berg; F Gao; G Coppola; B S Abrahams; D H Geschwind
Journal:  Mol Psychiatry       Date:  2014-10-14       Impact factor: 15.992

8.  Meta-analysis of GABRB3 Gene Polymorphisms and Susceptibility to Autism Spectrum Disorder.

Authors:  Rezvan Noroozi; Mohammad Taheri; Soudeh Ghafouri-Fard; Zeinab Bidel; Mir Davood Omrani; Ali Sanjari Moghaddam; Parisa Sarabi; Alireza Mosavi Jarahi
Journal:  J Mol Neurosci       Date:  2018-07-18       Impact factor: 3.444

9.  Aneuploid cells are differentially susceptible to caspase-mediated death during embryonic cerebral cortical development.

Authors:  Suzanne E Peterson; Amy H Yang; Diane M Bushman; Jurjen W Westra; Yun C Yung; Serena Barral; Tetsuji Mutoh; Stevens K Rehen; Jerold Chun
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

10.  Recent advances in the pathogenesis of syndromic autisms.

Authors:  A Benvenuto; B Manzi; R Alessandrelli; C Galasso; P Curatolo
Journal:  Int J Pediatr       Date:  2009-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.